Improving the Lives of Patients with Transformational Approaches in Gene and Cell Therapies.

  • CEO: Randal Kirk
  • Location: Germantown, MA
  • Milestones: May 2013 - Third Point Ventures initial investment, Aug 2013 - Intrexon IPO (NASDAQ: PGEN)
Go to site

Intrexon is an innovative leader in synthetic biology with a unique proposition, proven leadership team, and potential to transform multiple industries, including the health, food, and energy markets.